+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Colon Cancer"

From
Chemotherapy At-Home Services - Global Strategic Business Report - Product Thumbnail Image

Chemotherapy At-Home Services - Global Strategic Business Report

  • Report
  • November 2025
  • 179 Pages
  • Global
From
Genomics in Cancer Care - Global Strategic Business Report - Product Thumbnail Image

Genomics in Cancer Care - Global Strategic Business Report

  • Report
  • November 2025
  • 381 Pages
  • Global
From
Oncology Nutrition - Global Strategic Business Report - Product Thumbnail Image

Oncology Nutrition - Global Strategic Business Report

  • Report
  • November 2025
  • 352 Pages
  • Global
From
Polyp Biopsy Market Report 2025 - Product Thumbnail Image

Polyp Biopsy Market Report 2025

  • Report
  • October 2025
  • 250 Pages
  • Global
From
Tumor Models Market Report 2025 - Product Thumbnail Image

Tumor Models Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Tumor Microenvironment Global Market Report 2025 - Product Thumbnail Image

Tumor Microenvironment Global Market Report 2025

  • Report
  • July 2025
  • 175 Pages
  • Global
From
From
From
From
From
Pipeline of EpCAM-Targeted Immunotherapies - Product Thumbnail Image

Pipeline of EpCAM-Targeted Immunotherapies

  • Report
  • November 2025
  • Global
From
Loading Indicator

Colon cancer is a type of cancer that affects the large intestine, or colon. It is the third most common type of cancer in the world and is the second leading cause of cancer-related deaths in the United States. In oncology, colon cancer is typically treated with a combination of surgery, chemotherapy, and radiation therapy. Surgery is the most common treatment, and it is used to remove the tumor and any affected lymph nodes. Chemotherapy and radiation therapy are used to kill any remaining cancer cells. The colon cancer market is a rapidly growing segment of the oncology market. It is driven by the increasing prevalence of the disease, advances in treatment options, and the availability of new drugs. Companies in the market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, and Roche. Show Less Read more